Latest in Regenerative Medicine

Kyoto University has generated iPS cells with less risk of rejection by genome editing

•
March 1, 2021
•
Cancer

Kyoto University has succeeded in regenerating T-cells from human iPS cells that enhance effects of cancer immunotherapy(2018)

•
February 22, 2021
•
Cancer

Kyoto University developed a scalable method to regenerate T-cells from iPSCs

•
February 3, 2021
•
Cancer

Alzheimer’s patient iPS-derived neurons lead to the discovery of genetic mechanisms underlying the cause of disease.

•
December 4, 2020
•
Ophthalmic / Neurological Disorders

Novel approach to an iPS cell-based therapy for cervical cancer

•
November 14, 2020
•
Cancer

Stanford researchers use iPSCs to model heart disease in a dish and discover potential drug for treatment

•
October 2, 2020
•
Heart Disease

Clinical trial of iPSC-derived MSCs for treatment of steroid-resistant Graft-versus-host disease

•
September 25, 2020
•
Other

Reach out to us to learn more

Contact Us